Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Operating Activities:
Net income	$ 4,724	$ 3,868
Adjustments to reconcile net income to net cash provided by operating activities-
Provision for loan losses	450	300
Depreciation and amortization	683	694
Net amortization of premiums and discounts on securities	283	482
SBA discount accretion	(151)	(111)
Gain from bargain purchase of NJCB	(184)	0
Gains on sales and calls of securities available for sale	(12)	(104)
Gains on sales of other real estate owned	0	(14)
Gains on sales of loans held for sale	(2,133)	(2,607)
Originations of loans held for sale	(54,025)	(52,391)
Proceeds from sales of loans held for sale	51,121	66,233
Income on Bank–owned life insurance	(287)	(260)
Loss on cash surrender value on Bank-owned life insurance	14	0
Share-based compensation expense	506	484
(Increase) decrease in accrued interest receivable	(48)	35
Increase in other assets	(503)	(899)
Increase (decrease) in accrued interest payable	45	(54)
Increase (decrease) in accrued expenses and other liabilities	8,415	(806)
Net cash provided by operating activities	8,898	14,850
Purchases of securities:
Available for sale	(24,059)	(25,752)
Held to maturity	(2,868)	(16,460)
Proceeds from maturities and payments of securities:
Available for sale	8,949	11,231
Held to maturity	17,694	17,645
Proceeds from sales of securities:
Available for sale	0	5,728
Held to maturity	0	606
Proceeds from Bank-owned life insurance benefits paid	893	0
Net purchase of restricted stock	(4,600)	(105)
Net increase in loans	(35,999)	(38,242)
Capital expenditures	(479)	(439)
Forfeitable deposit on other real estate owned	100	0
Cost of improvements to OREO	0	(5)
Net cash paid for acquisition of NJCB	(996)	0
Proceeds from sales of other real estate owned	0	284
Net cash used in investing activities	(41,365)	(45,509)
Financing Activities:
Exercise of stock options	67	113
Cash dividends paid to shareholders	(986)	(803)
Net (decrease) increase in deposits	(52,442)	29,899
Increase in short-term borrowings	97,725	775
Net cash provided by financing activities	44,364	29,984
Increase (decrease) in cash and cash equivalents	11,897	(675)
Cash and Cash Equivalents at Beginning of Period	18,754	14,886
Cash and Cash Equivalents at End of Period	30,651	14,211
Cash paid during the period for -
Interest	3,193	2,683
Income taxes	3,226	1,577
Transfer of loans to other real estate owned	93	$ 455
Noncash assets acquired:
Investment securities available for sale	11,173
Loans	75,144
Premises and equipment, net	1,120
Bank-owned life insurance	3,972
Accrued interest receivable	259
Core deposit intangible asset	80
Other assets	2,786
Value of assets	94,534
Liabilities assumed:
Deposits	87,223
Other liabilities	636
Value of liabilities	87,859
Common stock issued as consideration	$ 5,495